# Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

> **NCT00763438** · PHASE4 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 18 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Sertindole

## Key facts

- **NCT ID:** NCT00763438
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763438, "Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00763438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*